Lamers, L.M. (Leida)

Update Persondata

• health
• risk
• treatment

Publications

(the most recent at the top)

Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: A report from the EORTC 26981/22981 NCI-C CE3 intergroup study

Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information

Risk-adjusted capitation: recent experiences in The Netherlands

Vertraging bij de opname van hartinfarctpatienten